Exodus Point Capital Management, LP Monte Rosa Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 265,278 shares of GLUE stock, worth $965,611. This represents 0.01% of its overall portfolio holdings.
Number of Shares
265,278
Previous 619,248
57.16%
Holding current value
$965,611
Previous $2.97 Million
36.95%
% of portfolio
0.01%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding GLUE
# of Institutions
71Shares Held
34.5MCall Options Held
80.3KPut Options Held
12.6K-
Nea Management Company, LLC Timonium, MD7.69MShares$28 Million3.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.1MShares$18.6 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$17.9 Million0.44% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.54MShares$16.5 Million0.39% of portfolio
-
Black Rock Inc. New York, NY2.31MShares$8.4 Million0.0% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $170M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...